Skip to primary navigation Skip to main content
0 item $0.00

  1. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40(10):e573-83.
  2. Agrotis A, Koulis C. STIM1, a new therapeutic target in occlusive vascular disease? Cardiovasc Res 2009;81(4):627-8. Editorial.
  3. Ahrens I, Bode C. Novel antiplatelet therapies following percutaneous coronary interventions. Curr Opin Investig Drugs 2009;10(9):902-11. Review.
  4. Ahrens I, Peter K. FX-06, a fibrin-derived B15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction. Curr Opin Investig Drugs 2009;10(9):997-1003. Review.
  5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640-5. Joint scientific statement.
  6. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favaloro JL, Triggle CR, Kemp-Harper BK. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br J Pharmacol 2009;157(4):540-50.
  7. Azzi S, Rossignol S, Steunou V, Sas T, Thibaud N, Danton F, Le Jule M, Heinrichs C, Cabrol S, Gicquel C, Le Bouc Y, Netchine I. Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Hum Mol Genet 2009;18(24):4724-33.
  8. Bailie RS, Si D, Dowden MC, Selvey CE, Kennedy C, Cox R, O'Donoghue L, Liddle H, Connors CM, Thompson S, Burke H, Brown A. A systems approach to improving timeliness of immunisation. Vaccine 2009;27(27):3669-74.
  9. Balasubramaniam R, Kistler PM. AF and heart failure: the chicken or the egg? Heart 2009;95(7):535-9. Review.
  10. Ballinger ML, Ivey ME, Osman N, Thomas WG, Little PJ. Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL. Atherosclerosis 2009;205(2):451-7.
  11. Barlovic DP, Cooper ME. Diabetes: RAS inhibition: probably not a one-size-fits-all approach. Nat Rev Nephrol 2009;5(12):669-70. Review.
  12. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009;52(3):415-24.
  13. Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Intern Med J 2009;39(1):49-53.
  14. Baumert M, Lambert GW, Dawood T, Lambert EA, Esler MD, McGrane M, Barton D, Sanders P, Nalivaiko E. Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol 2009;297(2):H674-9.
  15. Bays HE, Laferrère B, Dixon J, Aronne L, González-Campoy JM, Apovian C, Wolfe BM; Adiposopathy and Bariatric Surgery Working Group. Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease? Int J Clin Pract 2009;63(9):1285-300.
  16. Berry PA, Davies-Tuck ML, Wluka AE, Hanna FS, Bell RJ, Davis SR, Adams J, Cicuttini FM. The natural history of bone marrow lesions in community-based middle-aged women without clinical knee osteoarthritis. Semin Arthritis Rheum 2009;39(3):213-7.
  17. Bertovic DA, Dart AM. Importance of aortic dimensions in determining pulse pressure in elderly hypertensives. Asia-Pacific Cardiol 2009;2(1):35-37.
  18. Bhoyrul S, Dixon J, Fielding G, Ren Fielding C, Patterson E, Grossbard L, Shayani V, Bessler M, Voellinger D, Billy H, Cywes R, Ehrlich TB, Jones DB, Watkins BM, Ponce J, Brengman M, Schroder G. Safety and effectiveness of bariatric surgery: Roux-en-y gastric bypass is superior to gastric banding in the management of morbidly obese patients: a response. Patient Saf Surg 2009;3(1):17. Letter.
  19. Bobik A. Secretory phospholipase A2 type IIA: a regulator of immune function in atherosclerosis? Cardiovasc Res 2009;81(1):9-10. Editorial.
  20. Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, Bateman T, Nebelsiek T, Lundgren-May T, Canli O, Schwitalla S, Matthews V, Schmid RM, Kirchner T, Arkan MC, Ernst M, Greten FR. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009;15(2):91-102.
  21. Boyde M, Tuckett A, Peters R, Thompson D, Turner C, Stewart S. Learning for heart failure patients (The L-HF patient study). J Clin Nurs 2009;18(14):2030-9.
  22. Boyde M, Tuckett A, Peters R, Thompson DR, Turner C, Stewart S. Learning style and learning needs of heart failure patients (The Need2Know-HF patient study). Eur J Cardiovasc Nurs 2009;8(5):316-22.
  23. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW, Collier G, Blangero J, Walder K, Jowett JB. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 2009;94(8):3085-8.
  24. Brady SR, de Courten B, Reid CM, Cicuttini FM, de Courten MP, Liew D. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol 2009;36(1):34-40.
  25. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009;58(5):1229-36.
  26. Brennan SL, Pasco JA, Urquhart DM, Oldenburg B, Hanna F, Wluka AE. The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review. Osteoporosis Int 2009;20(9):1487-97.
  27. Brinkworth GD, Buckley JD, Noakes M, Clifton PM, Wilson CJ. Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function. Arch Intern Med 2009;169(20):1873-80.
  28. Brown A. Bridging the survival gap between Indigenous and non-Indigenous Australians: priorities for the road ahead. Heart Lung Circ 2009;18(2):96-100.
  29. Brown AD, Barton DA, Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 2009;23(7):583-602. Review.
  30. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, Carpenter K, Cooney GJ, Febbraio MA, Kraegen EW. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high fat diet-induced insulin resistance. Diabetes 2009;58(3):550-8.
  31. Bui BV, Loeliger M, Thomas M, Vingrys AJ, Rees SM, Nguyen CT, He Z, Tolcos M. Investigating structural and biochemical correlates of ganglion cell dysfunction in streptozotocin-induced diabetic rats. Exp Eye Res 2009;88(6):1076-83.
  32. Burke SL, Head GA. Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits: effect of rilmenidine. J Hypertens 2009;27(1):132-41.
  33. Butler MJ, Eccleston D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan A, New G, Black A, Szto G, Reid CM, Yan BP, Shaw JA, Dart AM, Duffy SJ; Melbourne Interventional Group. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am Heart J 2009;157(5):899-907.
  34. Cadilhac DA, Carter R, Thrift AG, Dewey HM. Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2009;40(3):915-21.
  35. Calcutt NA, Cooper ME, Kern TS, Schmidt AM. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 2009;8(5):417-29. Review.
  36. Calkin AC, Drew BG, Ono A, Duffy SJ, Gordon MV, Schoenwaelder SM, Sviridov D, Cooper ME, Kingwell BA, Jackson SP. Reconstituted high-density lipoprotein attenuates platelet function in individuals with Type 2 diabetes mellitus by promoting cholesterol efflux. Circulation 2009;120(21):2095-104.
  37. Cameron AJ, Dunstan DW, Owen N, Zimmet PZ, Barr EL, Tonkin AM, Magliano DJ, Murray SG, Welborn TA, Shaw JE. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study. Med J Aust 2009;191(4):202-8.
  38. Cameron AJ, Zimmet PZ, Shaw JE, Alberti KG. The metabolic syndrome: in need of a global mission statement. Diabet Med 2009;26(3):306-9.
  39. Cameron J, Worrall-Carter L, Driscoll A, Stewart S. Measuring self-care in chronic heart failure: a review of the psychometric properties of clinical instruments. J Cardiovasc Nurs 2009;24(6):E10-22.
  40. Cameron J, Worrall-Carter L, Riegel B, Lo SK, Stewart S. Testing a model of patient characteristics, psychologic status, and cognitive function as predictors of self-care in persons with chronic heart failure. Heart Lung 2009;38(5):410-8.
  41. Campbell I, Polyak K, Haviv I. Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution. Cancer Res 2009;69(17):6765-9. Review.
  42. Camuglia A, Manins V, Taylor A, Hengel C. Case report and review: epicardial coronary artery fibromuscular dysplasia. Heart Lung Circ 2009;18(2):151-4. Review.
  43. Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, Gerstein M, Weissman SM. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc Natl Acad Sci USA 2009;106(52):22421-6.
  44. Candido R, Bernardi S, Allen TJ. Linking diabetes and atherosclerosis. Expert Rev Endocrinol Metab 2009;4(6):603-24. Review.
  45. Carey AL, Kingwell BA. Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with 'exercise mimetics'. Diabetologia 2009;52(10):2015-26. Review.
  46. Carrington M. Prehypertension causes a mounting problem of harmful cardiovascular disease risk in young adults. J Hypertens 2009;27(2):214-5.
  47. Carrington MJ, Retegan C, Johnston CI, Jennings GL, Stewart S. Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention. J Clin Nurs 2009;18(5):678-86.
  48. Cauza E, Strehblow C, Metz-Schimmerl S, Strasser B, Hanusch-Enserer U, Kostner K, Dunstan D, Fasching P, Haber P. Effects of progressive strength training on muscle mass in Type 2 diabetes mellitus patients determined by computed tomography. Wien Med Wochenschr 2009;159(5-6):141-7.
  49. Chan W, Sviridov D, Dart AM. HIV, atherosclerosis and inflammation: implications for treatment. J HIV Therapy 2009:14(3);1-8. Review.
  50. Chen D, La Greca L, Head GA, Walther T, Mayorov DN. Blood pressure reactivity to emotional stress is reduced in AT1A-receptor knockout mice on normal, but not high salt intake. Hypertens Res 2009;32(7):559-64.
  51. Chen L, Tonkin AM, Moon L, Mitchell P, Dobson A, Giles G, Hobbs M, Phillips PJ, Shaw JE, Simmons D, Simons LA, Fitzgerald AP, De Backer G, De Bacquer D. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart. Eur J Cardiovasc Prev Rehabil 2009;16(5):562-70.
  52. Chew P, Yuen DY, Koh P, Stefanovic N, Febbraio MA, Kola I, Cooper ME, de Haan JB. Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse. Arterioscler Thromb Vasc Biol 2009;29(6):823-30.
  53. Colomiere M, Permezel M, Riley C, Desoye G, Lappas M. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 2009;160(4):567-78.
  54. Cooper ME. Metabolic memory: implications for diabetic vascular complications. Pediatr Diabetes 2009;10(5):343-6. Editorial.
  55. Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan AL, Fukami K, Thallas-Bonke V, Nawroth PP, Brownlee M, Bierhaus A, Cooper ME, Forbes JM. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol 2009;20(4):742-52.
  56. Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL. The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics. Clin Res Cardiol 2009;98(7):421-33.
  57. Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL; ONTARGET Investigators. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol 2009;104(11):1484-9.
  58. Coyne T, Ibiebele TI, Baade PD, McClintock CS, Shaw JE. Metabolic syndrome and serum carotenoids: findings of a cross-sectional study in Queensland, Australia. Br J Nutr 2009;102(11):1668-77.
  59. Cust AE, Skilton MR, van Bakel MM, Halkjaer J, Olsen A, Agnoli C, Psaltopoulou T, Buurma E, Sonestedt E, Chirlaque MD, Rinaldi S, Tjønneland A, Jensen MK, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Nöthlings U, Chloptsios Y, Zylis D, Mattiello A, Caini S, Ocké MC, van der Schouw YT, Skeie G, Parr CL, Molina-Montes E, Manjer J, Johansson I, McTaggart A, Key TJ, Bingham S, Riboli E, Slimani N. Total dietary carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 2009:63 Suppl 4;S37-60.
  60. Dart AM. To what extent has monitoring of heart rate reduction become part of your daily practice? Medicographia 2009;31(4):397. Comment.
  61. Davern PJ, Chen D, Head GA, Chavez CA, Walther T, Mayorov DN. Role of angiotensin II Type 1A receptors in cardiovascular reactivity and neuronal activation after aversive stress in mice. Hypertension 2009;54(6):1262-8.
  62. Davern PJ, Nguyen-Huu TP, La Greca L, Abdelkader A, Head GA. Role of the sympathetic nervous system in Schlager genetically hypertensive mice. Hypertension 2009;54(4):852-9.
  63. Davidson PM, Stewart S. Heart failure nursing in Australia: past, present and future. Aust Crit Care 2009;22(3):108-10. Editorial.
  64. Davies-Tuck ML, Hanna F, Davis SR, Bell RJ, Davison SL, Wluka AE, Adams J, Cicuttini FM. Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther 2009;11(6):R181.
  65. Davies-Tuck ML, Wluka AE, Forbes A, Wang Y, English DR, Giles GG, Cicuttini F. Smoking is associated with increased cartilage loss and persistence of bone marrow lesions over 2 years in community-based individuals. Rheumatology 2009;48(10):1227-31.
  66. Davies-Tuck ML, Wluka AE, Wang Y, English DR, Giles GG, Cicuttini FM. The natural history of bone marrow lesions in community based adults with no clinical knee osteoarthritis. Ann Rheum Dis 2009;68(6):904-8.
  67. Davis DR, Zhang Y, Smith RR, Cheng K, Terrovitis J, Malliaras K, Li TS, White A, Makkar R, Marbán E. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 2009;4(9):e7195.
  68. Dawood T, Schlaich M, Brown A, Lambert G. Depression and blood pressure control: all antidepressants are not the same. Hypertension 2009;54(1):e1. Letter.
  69. Dawood T, Schlaich MP. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation. Minerva Cardioangiol 2009;57(6):687-704.
  70. Dawson AP, Steele EJ, Hodges PW, Stewart S. Development and test-retest reliability of an extended version of the Nordic Musculoskeletal Questionnaire (NMQ-E): a screening instrument for musculoskeletal pain. J Pain 2009;10(5):517-26.
  71. de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J; ADVANCE Collaborative Group. Lowering blood pressure reduces renal events in Type 2 diabetes. J Am Soc Nephrol 2009;20(4):883-92.
  72. de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J; ADVANCE Collaborative Group. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with Type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 2009;30(9):1128-35.
  73. de la Barra SL, Redman S, Eades S. Health research policy: a case study of policy change in Aboriginal and Torres Strait Islander health research. Aust New Zealand Health Policy 2009;6:2.
  74. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. Clin Ther 2009;31(2):236-44.
  75. De Silva DA, Woon FP, Gan HY, Chen CP, Chang HM, Koh TH, Kingwell BA, Cameron JD, Wong MC. Arterial stiffness is associated with intracranial large artery disease among ethnic Chinese and South Asian ischemic stroke patients. J Hypertens 2009;27(7):1453-8.
  76. Denton DA, McKinley MJ, Farrell M, Egan GF. The role of primordial emotions in the evolutionary origin of consciousness. Conscious Cogn 2009;18(2):500-14.
  77. Dixon A, Rosengren H, Connelly T, Dixon J. Education in skin cancer management - assessing knowledge and safety. Aust Fam Physician 2009;38(7):557-60.
  78. Dixon AJ, Dixon MP, Dixon JB. Prospective study of skin surgery in patients with and without known diabetes. Dermatol Surg 2009;35(7):1035-40.
  79. Dixon AJ, Dixon MP, Dixon JB. Skin surgery to the ear risks increased bleeding complications - a prospective study. J Plast Reconstr Aesthet Surg 2009;62(1):123-5.
  80. Dixon AJ, Dixon MP, Dixon JB, Del Mar CB. Prospective study of skin surgery in smokers vs. nonsmokers. Br J Dermatol 2009;160(2):365-7.
  81. Dixon JB. Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg 2009;19(5):641-4. Review.
  82. Dixon JB. Obesity and diabetes: the impact of bariatric surgery on Type-2 diabetes. World J Surg 2009;33(10):2014-21. Review.
  83. Dixon JB, Jones K, Dixon M. Medical versus surgical interventions for the metabolic complications of obesity in children. Semin Pediatr Surg 2009;18(3):168-75.
  84. Dixon JB, Laurie CP, Anderson ML, Hayden MJ, Dixon ME, O'Brien PE. Motivation, readiness to change, and weight loss following adjustable gastric band surgery. Obesity 2009;17(4):698-705.
  85. Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, de Courten B, Forbes JM, Yap FY, Kaye DM, van Hall G, Febbraio MA, Kemp BE, Sviridov D, Steinberg GR, Kingwell BA. High-density lipoprotein modulates glucose metabolism in patients with Type 2 diabetes mellitus. Circulation 2009;119(15):2103-11.
  86. Driscoll A, Worrall-Carter L, Hare DL, Davidson PM, Riegel B, Tonkin A, Stewart S. Evidence-based chronic heart failure management programs: reality or myth? Qual Saf Health Care 2009;18(6):450-5.
  87. Du XJ, Xu Q, Lekgabe E, Gao XM, Kiriazis H, Moore XL, Dart AM, Tregear GW, Bathgate RA, Samuel CS. Reversal of cardiac fibrosis and related dysfunction by relaxin. Ann NY Acad Sci 2009;1160:287-84.
  88. Dwyer T, Magnussen CG, Schmidt MD, Ukoumunne OC, Ponsonby AL, Raitakari OT, Zimmet PZ, Blair SN, Thomson R, Cleland VJ, Venn A. Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults. Diabetes Care 2009;32(4):683-7.
  89. Egger G, Dixon J. Obesity and chronic disease: always offender or often just accomplice? Br J Nutr 2009;102(8):1238-42. Review.
  90. Egger G, Dixon J. Should obesity be the main game? Or do we need an environmental makeover to combat the inflammatory and chronic disease epidemics? Obes Rev 2009;10(2):237-49. Review.
  91. Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, Bassler N, Qian H, von Zur Muhlen C, Hagemeyer CE, Ahrens I, Chin-Dusting J, Bobik A, Peter K. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 2009;105(2):128-37.
  92. Eisenhardt SU, Habersberger J, Peter K. Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk. Trends Cardiovasc Med 2009;19(7):232-7. Review.
  93. Eisenhardt SU, Thiele JR, Bannasch H, Stark GB, Peter K. C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 2009;8(23):3885-92. Review.
  94. Esler M. Depressive illness, the sympathetic nervous system and cardiac risk. J Hypertens 2009;27(12):2349-50. Editorial.
  95. Esler MD. Heart and mind: psychogenic cardiovascular disease. J Hypertens 2009;27(4):692-5. Editorial.
  96. Filtz TM, Grubb DR, McLeod-Dryden TJ, Luo J, Woodcock EA. Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase C1b. FASEB J 2009;23(10):3564-70.
  97. Forrester JS, White AJ, Matsushita S, Chakravarty T, Makkar RR. New paradigms of myocardial regeneration post-infarction: tissue preservation, cell environment, and pluripotent cell sources. JACC Cardiovasc Interv 2009;2(1):1-8. Review.
  98. Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM; Melbourne Interventional Group. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheter Cardiovasc Interv 2009;73(6):763-8.
  99. Freilich M, Stub D, Esmore D, Negri J, Salamonsen R, Bergin P, Leet A, Richardson M, Taylor A, Woodard J, Kaye D, Rosenfeldt F. Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device. J Heart Lung Transplant 2009;28(1):101-3.
  100. Gall SL, Dewey HM, Sturm JW, Macdonell RA, Thrift AG. Handicap 5 years after stroke in the North East Melbourne Stroke Incidence Study. Cerebrovasc Dis 2009;27(2):123-130.
  101. Gall SL, Dewey HM, Thrift AG. Smoking cessation at 5 years after stroke in the North East Melbourne stroke incidence study. Neuroepidemiology 2009;32(3):196-200.
  102. Gao WG, Qiao Q, Pitkäniemi J, Wild S, Magliano D, Shaw J, Sőderberg S, Zimmet P, Chitson P, Knowlessur S, Alberti G, Tuomilehto J. Risk prediction models for the development of diabetes in Mauritian Indians. Diabet Med 2009;26(10):996-1002.
  103. German JB, Gibson RA, Krauss RM, Nestel P, Lamarche B, van Staveren WA, Steijns JM, de Groot LC, Lock AL, Destaillats F. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr 2009;48(4):191-203. Review.
  104. Gilligan C, Sanson-Fisher RW, D'Este C, Eades S, Wenitong M. Knowledge and attitudes regarding smoking during pregnancy among Aboriginal and Torres Strait Islander women. Med J Aust 2009;190(10):557-61.
  105. Gregorevic P, Schultz BR, Allen JM, Halldorson JB, Blankinship MJ, Meznarich NA, Kuhr CS, Doremus C, Finn E, Liggitt D, Chamberlain JS. Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature. Mol Ther 2009;17(8):1427-33.
  106. Groop PH, Thomas MC, Moran JL, Wadèn J, Thorn LM, Mäkinen VP, Rosengård-Bärlund M, Saraheimo M, Hietala K, Heikkilä O, Forsblom C; FinnDiane Study Group. The presence and severity of chronic kidney disease predicts all-cause mortality in Type 1 diabetes. Diabetes 2009;58(7):1651-8.
  107. Grossmann M, Panagiotopolous S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G, Thomas MC. Low testosterone and anaemia in men with Type 2 diabetes. Clin Endocrinol 2009;70(4):547-53.
  108. Haase-Fielitz A, Haase M, Bellomo R, Lambert G, Matalanis G, Story D, Doolan L, Buxton B, Gutteridge G, Luft FC, Schunck WH, Dragun D. Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009;20(6):1393-403.
  109. Hagemeyer CE, Peter K. Ex-vivo thrombolytic gene therapy for vein graft patency: the frontier for development of selective, localised therapeutic approaches. Thromb Haemost 2009;102(1):3-4.
  110. Hagemeyer CE, von Zur Muhlen C, von Elverfeldt D, Peter K. Single-chain antibodies as diagnostic tools and therapeutic agents. Thromb Haemost 2009;101(6):1012-9. Review.
  111. Halls ML, Hewitson TD, Moore XL, Du XJ, Bathgate RA, Summers RJ. Relaxin activates multiple cAMP signaling pathway profiles in different target cells. Ann N Y Acad Sci 2009;1160:108-11.
  112. Hanna FS, Teichtahl AJ, Wluka AE, Wang Y, Urquhart DM, English DR, Giles GG, Cicuttini FM. Women have increased rates of cartilage loss and progression of cartilage defects at the knee than men: a gender study of adults without clinical knee osteoarthritis. Menopause 2009;16(4):666-70.
  113. Hauke J, Riessland M, Lunke S, Eyüpoglu IY, Blümcke I, El-Osta A, Wirth B, Hahnen E. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 2009;18(2):304-17.
  114. Haviv I, Polyak K, Qiu W, Hu M, Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle 2009;8(4):589-95. Review.
  115. Hennebry SC. Evolutionary changes to transthyretin: structure and function of a transthyretin-like ancestral protein. FEBS J 2009;276(19):5367-79. Review.
  116. Henstridge DC, Drew BG, Formosa MF, Natoli AK, Cameron-Smith D, Duffy SJ, Kingwell BA. The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. Nitric Oxide 2009;21(2):126-31.
  117. Henstridge DC, Duffy SJ, Formosa MF, Ahimastos AA, Thompson BR, Kingwell BA. Oral nitrate therapy does not affect glucose metabolism in healthy humans. Clin Exp Pharmacol Physiol 2009;36(11):1086-92.
  118. Herath CB, Lubel JS, Jia Z, Velkoska E, Casley D, Brown L, Tikellis C, Burrell LM, Angus PW. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. Am J Physiol Gastrointest Liver Physiol 2009;297(1):G98-G106.
  119. Holdsworth-Carson SJ, Permezel M, Rice GE, Lappas M. Preterm and infection-driven preterm labor: the role of peroxisome proliferator-activated receptors and retinoid X receptor. Reproduction 2009;137(6):1007-15.
  120. Hoppe CC, Moritz KM, Fitzgerald SM, Bertram JF, Evans RG. Transient hypertension and sustained tachycardia in mice housed individually in metabolism cages. Physiol Res 2009;58(1):69-75.
  121. Hoy AJ, Brandon AE, Turner N, Watt MJ, Bruce CR, Cooney GJ, Kraegen EW. Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation. Am J Physiol Endocrinol Metab 2009;297(1):E67-75.
  122. Hu H, Straub A, Tian Z, Bassler N, Cheng J, Peter K. Celastrol, a triterpene extracted from Tripterygium wilfordii Hook F, inhibits platelet activation. J Cardiovasc Pharmacol 2009;54(3):240-5.
  123. Huynh NN, Andrews KL, Head GA, Khong SM, Mayorov DN, Murphy AJ, Lambert G, Kiriazis H, Xu Q, Du XJ, Chin-Dusting JP. Arginase II knockout mouse displays a hypertensive phenotype despite a decreased vasoconstrictory profile. Hypertension 2009;54(2):294-301.
  124. Huynh NN, Harris E, Chin-Dusting J, Andrews K. The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries. Br J Pharmacol 2009;156(1):84-93.
  125. Jandeleit-Dahm KAM, Allen TJ. Hot Topics - Hypertension and Diabetes: An emphasis on the RAS. Curr Diabetes Rev 2009;5(3):166-7. Editorial.
  126. Jandeleit-Dahm KA, Calkin A, Tikellis C, Thomas M. Direct antiatherosclerotic effects of PPAR agonists. Curr Opin Lipidol 2009;20(1):24-9. Review.
  127. Jelinek M, Vale MJ, Liew D, Grigg L, Dart A, Hare DL, Best JD. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up. Heart Lung Circ 2009;18(6):388-92.
  128. Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JW, Capewell S, McMurray JJ. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009;119(4):515-23.
  129. Jones KM, Dixon ME, Dixon JB. Childhood obesity, BMI calculators, and medical software - time for an upgrade? Aust Fam Physician 2009;38(9):731-2. Review.
  130. Joubert J, Reid C, Barton D, Cumming T, McLean A, Joubert L, Barlow J, Ames D, Davis S. Integrated care improves risk factor modification one year after stroke: initial results of the ICARUSS model. J Neurol Neurosurg Psychiatry 2009;80(3):279-84.
  131. Jowett J. GATTACA - are we there yet? Nat Rev Endocrinol 2009;5(4):187-8. Comment.
  132. Jowett JB, Diego VP, Kotea N, Kowlessur S, Chitson P, Dyer TD, Zimmet P, Blangero J. Genetic influences on Type 2 diabetes and metabolic syndrome related quantitative traits in Mauritius. Twin Res Hum Genet 2009;12(1):44-52.
  133. Kaminskas LM, Kelly BD, McLeod VM, Boyd BJ, Krippner GY, Williams ED, Porter CJ. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-L-lysine dendrimers. Mol Pharm 2009;6(4):1190-204.
  134. Kaminskas LM, Wu Z, Barlow N, Krippner GY, Boyd BJ, Porter CJ. Partly-PEGylated poly-L-lysine dendrimers have reduced plasma stability and circulation times compared with fully PEGylated dendrimers. J Pharm Sci 2009;98(10):3871-5.
  135. Kampe J, Brown WA, Stefanidis A, Dixon JB, Oldfield BJ. A rodent model of adjustable gastric band surgery-implications for the understanding of underlying mechanisms. Obes Surg 2009;19(5):625-31.
  136. Kanellakis P, Pomilio G, Walker C, Husband A, Huang JL, Nestel P, Agrotis A, Bobik A. A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-B signaling. Atherosclerosis 2009;204(1):66-72.
  137. Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ, O'Brien PE. Cost-effectiveness of surgically induced weight loss for the management of Type 2 diabetes: modeled lifetime analysis. Diabetes Care 2009;32(4):567-74.
  138. Keating CL, Dixon JB, Moodie ML, Peeters A, Playfair J, O'Brien PE. Cost-efficacy of surgically induced weight loss for the management of Type 2 diabetes: a randomized controlled trial. Diabetes Care 2009;32(4):580-4.
  139. Kemp W, Colman J, Thompson K, Madan A, Vincent M, Chin-Dusting J, Kompa A, Krum H, Roberts S. Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial. Liver Int 2009;299(3):427-33.
  140. Kengne AP, Czernichow S, Huxley R, Grobbee D, Woodward M, Neal B, Zoungas S, Cooper M, Glasziou P, Hamet P, Harrap SB, Mancia G, Poulter N, Williams B, Chalmers J; ADVANCE Collaborative Group. Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension 2009;54(2):399-404.
  141. Khachigian LM, Peter K, Berndt MC. Recent advances in vascular biology: selected highlights from IVBM 2008. Thromb Haemost 2009;101(6):997-8. Editorial.
  142. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ 2009;339:b4432. Analysis.
  143. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: response to the International Expert Committee. Diabetes Care 2009;32(12):e159. Letter.
  144. Koh PJ, Koitka A, Cooper ME, Allen TJ. Eplerenone does not attenuate diabetes-associated atherosclerosis. J Hypertens 2009;27(7):1431-8.
  145. Koska J, Ortega E, Bunt JC, Gasser A, Impson J, Hanson RL, Forbes J, de Courten B, Krakoff J. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia 2009;52(3):385-93.
  146. Kraegen EW, Bruce C, Hegarty BD, Ye JM, Turner N, Cooney G. AMP-activated protein kinase and muscle insulin resistance. Front Biosci 2009;14:4658-72. Review.
  147. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373(9671):1275-81.
  148. La Gerche A, Taylor AJ, Prior DL. Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. JACC Cardiovasc Imaging 2009;2(3):350-63. Review.
  149. Lancaster GI, Febbraio MA. Skeletal muscle: not simply an organ for locomotion and energy storage. J Physiol 2009;587(Pt3):509-10. Editorial.
  150. Lappas M, Riley C, Rice GE, Permezel M. Increased expression of ac-FoxO1 protein in prelabor fetal membranes overlying the cervix: possible role in human fetal membrane rupture. Reprod Sci 2009;16(7):635-41.
  151. Lee GA. Determinants of quality of life five years after coronary artery bypass graft surgery. Heart Lung 2009;38(2):91-9.
  152. Leet AS, Bergin PJ, Richardson M, Taylor AJ, Esmore D, Kaye DM. Outcomes following de novo CNI-free immunosuppression after heart transplantation: a single-center experience. Am J Transplant 2009:9(1);140-8.
  153. Lefkovits L, Taylor AJ. Screening for coronary artery disease in Type 2 diabetic patients. Diabetes Manag 2009;27:6-7.
  154. Leon de la Barra S, Redman S, Eades S, Lonsdale C. A decade of NHMRC People Support expenditure in review: is support for Indigenous health research increasing? Med J Aust 2009;190(1):28-31.
  155. Leong GR, Goulding KR, Amin N, Richardson HE, Brumby AM. Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs. BMC Biol 2009;7:62.
  156. Lim AK, Ma FY, Nikolic-Paterson DJ, Thomas MC, Hurst LA, Tesch GH. Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice. Diabetologia 2009;52(8):1669-79.
  157. Lim AK, Nikolic-Paterson DJ, Ma FY, Ozols E, Thomas MC, Flavell RA, Davis RJ, Tesch GH. Role of MKK3-p38 MAPK signalling in the development of Type 2 diabetes and renal injury in obese db/db mice. Diabetologia 2009;52(2):347-58.
  158. Lim HS, Farouque O, Andrianopoulos N, Yan BP, Lim CC, Brennan AL, Reid CM, Freeman M, Charter K, Black A, New G, Ajani AE, Duffy SJ, Clark DJ; Melbourne Interventional Group. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. JACC Cardiovasc Interv 2009;2(2):146-52.
  159. Lim SS, Norman RJ, Clifton PM, Noakes M. Psychological effects of prescriptive vs general lifestyle advice for weight loss in young women. J Am Diet Assoc 2009;109(11):1917-21.
  160. Little PJ, Cohen N, Morahan G. Potential of small molecule protein tyrosine kinase inhibitors as immuno-modulators and inhibitors of the development of Type 1 diabetes. ScientificWorldJournal 2009;9:224-8. Review.
  161. Löffler C, Straub A, Bassler N, Pernice K, Beyersdorf F, Bode C, Siegenthaler MP, Peter K. Evaluation of platelet activation in patients supported by the Jarvik 2000* high-rotational speed impeller ventricular assist device. J Thorac Cardiovasc Surg 2009;137(3):736-41.
  162. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, Stepto N, Wu B, Mitchell CA, Tonks NK, Watt MJ, Febbraio MA, Crack PJ, Andrikopoulos S, Tiganis T. Reactive oxygen species enhance insulin sensitivity. Cell Metab 2009;10(4):260-72.
  163. Luke JN, Brown A, O'Neal DN, O'Dea K, Jenkins AJ, Kelaher M, Best JD, Rowley KG. Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia. Med J Aust 2009;190(10):552-6.
  164. Lunke S, El-Osta A. The emerging role of epigenetic modifications and chromatin remodeling in spinal muscular atrophy. J Neurochem 2009;109(6):1557-69. Review.
  165. MacIsaac RJ, Barit D, Jerums G. Blood pressure lowering and outcomes in Type 2 diabetes: implications of the blood pressure-lowering arm of the advance trial. Curr Hypertens Rev 2009;5(3):168-80. Review.
  166. Macisaac RJ, Jerums G, Weekes AJ, Thomas MC. Patterns of glycaemic control in Australian primary care (NEFRON 8). Intern Med J 2009;39(8):512-8.
  167. Maeder MT. Cardiopulmonary exercise testing for the evaluation of unexplained dyspnea. Ther Umsch 2009;66(9):665-9. Review.
  168. Maeder MT, Ammann P, Münzer T. Peak oxygen consumption and heart rate recovery in patients with the obstructive sleep apnea syndrome. Chest 2009;135(2):584.
  169. Maeder MT, Ammann P, Rickli H, Brunner-La Rocca HP. Impact of the exercise mode on heart rate recovery after maximal exercise. Eur J Appl Physiol 2009;105(2):247-55.
  170. Maeder MT, Brutsche MH, Christ A, Reichlin T, Staub D, Noveanu M, Breidthardt T, Potocki M, Mueller C. Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease. Respir Med 2009;103(9):1337-45.
  171. Maeder MT, Brutsche MH, Staub D, Morgenthaler NG, Bergmann A, Noveanu M, Laule K, Breidthardt T, Christ A, Klima T, Reichlin T, Potocki M, Mueller C. B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption. J Intern Med 2009;265(5):604-15.
  172. Maeder MT, Kaye DM. Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2009;53(11):905-18. Review.
  173. Maeder MT, Leet A, Ross A, Esmore D, Kaye DM. Changes in right ventricular function during continuous-low left ventricular assist device support. J Heart Lung Transplant 2009;28(4):360-6.
  174. Maeder MT, Zellweger MJ. Diagnosis of coronary artery disease - part 1: General approach. Praxis 2009;98(19):1059-66. Review.
  175. Maeder MT, Zellweger MJ. Diagnosis of coronary artery disease - part 2: Exercise electrocardiogram and myocardial perfusion scintigraphy. Praxis 2009;98(19):1067-74. Review.
  176. Maeder MT, Zellweger MJ. Diagnosis of coronary artery disease - part 3: Stress echocardiography and cardiac magnetic resonance imaging. Praxis 2009;98(19):1075-81. Review.
  177. Maeder MT, Zellweger MJ. Diagnosis of coronary artery disease - part 4: Computed tomography and coronary angiography. Praxis 2009;98(19):1083-90. Review.
  178. Magliano DJ, Peeters A, Vos T, Sicree R, Shaw J, Sindall C, Haby M, Begg SJ, Zimmet PZ. Projecting the burden of diabetes in Australia - what is the size of the matter? Aust N Z J Public Health 2009;33(6):540-3.
  179. Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Kaski K, Ala-Korpela M, Groop PH. Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with Type 1 diabetes (the FinnDiane Study). Cardiovasc Diabetol 2009;8:54.
  180. Malalasekera V, Cameron F, Grixti E, Thomas MC. Potential reno-protective effects of a gluten-free diet in Type 1 diabetes. Diabetologia 2009;52(5):798-800.
  181. Manins V, Habersberger J, Pfluger H, Taylor AJ. Cardiac magnetic resonance imaging in the evaluation of cardiac sarcoidosis: an Australian single-centre experience. Intern Med J 2009;39(2):77-82.
  182. Marre M, Shaw J, Brändle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S; LEAD-1 SU study group. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabet Med 2009;26(3):268-78.
  183. Marwick TH, Branagan H, Venkatesh B, Stewart S; STRATIFY investigators. Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery. Am Heart J 2009;157(4):784-90.
  184. Masson R, Nicklin SA, Craig MA, McBride M, Gilday K, Gregorevic P, Allen JM, Chamberlain JS, Smith G, Graham D, Dominiczak AF, Napoli C, Baker AH. Onset of experimental severe cardiac fibrosis is mediated by overexpression of angiotensin-converting enzyme 2. Hypertension 2009;53(4):694-700.
  185. Masuo K, Lambert GW, Esler MD. Epinephrine and its role in the development of obesity, hypertension and obesity-related hypertension. Int J Med Biol Front 2009;15(5/6):371-86. Review.
  186. Masuo K, Lambert GW, Esler MD The role of sympathetic nerve activity, insulin resistance and -adrenoceptor polymorphisms in obesity and hypertension. Salud(i) Ciencia 2009.
  187. Matthews VB, Aström MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Akerström T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, Febbraio MA. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 2009;52(7):1409-18.
  188. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ, Mitchell P, Vingerling JR, de Jong PT, Witteman JC, Breteler MM, Shaw J, Zimmet P, Wong TY. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol 2009;170(11):1323-32.
  189. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ, Mitchell P, Vingerling JR, Dejong PT, Witteman JC, Breteler MM, Shaw J, Zimmet P, Wong TY. Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med 2009;151(6):404-13.
  190. McMullen JR. Nectin-2: an intercalated disc protein that maintains cardiac function in a setting of pressure overload. Hypertension 2009;54(4):713-5. Editorial.
  191. McMurray JJ, Jhund P, MacIntyre K, Stewart S. Heart failure in the UK. Heart 2009:95(2);156. Letter.
  192. McNaughton SA, Dunstan DW, Ball K, Shaw J, Crawford D. Dietary quality is associated with diabetes and cardio-metabolic risk factors. J Nutr 2009;139(4):734-42.
  193. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J, Guven S; American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity 2009;17 Suppl 1:S1-70, v.
  194. Medi C, Kalman JM, Haqqani H, Vohra JK, Morton JB, Sparks PB, Kistler PM. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol 2009;53(19):1791-7.
  195. Meng S, Fang L, Wang CQ, Wang LS, Chen MT, Huang XH. Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention. J Int Med Res 2009:37(5);1343-53.
  196. Mensink RP, Nestel P. Trans fatty acids and cardiovascular risk markers: does the source matter? Curr Opin Lipidol 2009;20(1):1-2. Editorial.
  197. Meyer RP, Gehlhaus M, Schwab R, Bürck C, Knoth R, Hagemeyer CE. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J Neurochem 2009;109(2):670-81.
  198. Michaels S, Eppel GA, Burke SL, Head GA, Armitage J, Carroll JF, Malpas SC, Evans RG. Altered responsiveness of the kidney to activation of the renal nerves in fat-fed rabbits. Am J Physiol Regul Integr Comp Physiol 2009;296(6):R1889-96.
  199. Miller F, Nagley P, Mariani JA, Ou R, Liu VW, Zhang C, Linnane AW, Pepe S, Rosenfeldt F. Age-related decline in stress responses of human myocardium may not be explained by changes in mtDNA. Mech Ageing Dev 2009;130(11-12):742-7.
  200. Mitchell DA, Lambert G, Secher NH, Raven PB, van Lieshout J, Esler MD. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans. J Physiol 2009;587(Pt 11):2589-97.
  201. Miura S, Kai Y, Kamei Y, Bruce CR, Kubota N, Febbraio MA, Kadowaki T, Ezaki O. 2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise. Am J Physiol Endocrinol Metab 2009;296(1):E47-55.
  202. Moore XL, Hong A, Du XJ. 1-adrenergic activation upregulates expression of relaxin receptor RXFP1 in cardiomyocytes. Ann N Y Acad Sci 2009;1160:285-6.
  203. Moretti JL, Burke SL, Evans RG, Lambert GW, Head GA. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension. J Hypertens 2009;27(9):1838-48.
  204. Mukhamedova N, Rose H, Cui HL, Grant A, Tchoua U, Dart A, Bukrinsky M, Sviridov D. Antiretroviral compounds and cholesterol efflux from macrophages. Atherosclerosis 2009;206(2):439-43.
  205. Murphy A, Chin-Dusting J, Sviridov D. Reconstituted HDL: a therapy for atherosclerosis and beyond. Clin Lipidol 2009:4(6);731-9. Review.
  206. Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ. The anti inflammatory effects of high density lipoproteins. Curr Med Chem 2009;16(6):667-75. Review.
  207. Murray G, Nicholas CL, Kleiman J, Dwyer R, Carrington MJ, Allen NB, Trinder J. Nature's clocks and human mood: the circadian system modulates reward motivation. Emotion 2009;9(5):705-16.
  208. Naik H, White AJ, Chakravarty T, Forrester J, Fontana G, Kar S, Shah PK, Weiss RE, Makkar R. A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv 2009;2(8):739-47. Review.
  209. Nathan DM, Balkau B, Bonora E, Borch-Johnsen K, Buse JB, Colagiuri S, Davidson MB, DeFronzo R, Genuth S, Holman RR, Ji L, Kirkman S, Knowler WC, Schatz D, Shaw J, Sobngwi E, Steffes M, Vaccaro O, Wareham N, Zinman B, Kahn R. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32(7):1327-34. .
  210. Nguyen TT, Kawasaki R, Kreis AJ, Wang JJ, Shaw J, Vilser W, Wong TY. Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci 2009;50(12):5609-13.
  211. Nguyen TT, Kawasaki R, Wang JJ, Kreis AJ, Shaw J, Vilser W, Wong TY. Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 2009;32(11):2075-80.
  212. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009;20(8):1813-21.
  213. Norman PE, Davis WA, Coughlan MT, Forbes JM, Golledge J, Davis TM. Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. J Vasc Surg 2009;50(3):626-31.
  214. Nyamdorj R, Qiao Q, Söderberg S, Pitkäniemi JM, Zimmet PZ, Shaw JE, Alberti KG, Pauvaday VK, Chitson P, Kowlessur S, Tuomilehto J. BMI compared with central obesity indicators as a predictor of diabetes incidence in Mauritius. Obesity 2009;17(2):342-8.
  215. Owen AJ, Retegan C, Rockell M, Jennings G, Reid CM. Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes. Clin Exp Pharmacol Physiol 2009;36(7):643-7.
  216. Owen KL, Pretorius L, McMullen JR. The protective effects of exercise and phosphoinositide 3-kinase (p110) in the failing heart. Clin Sci 2009;116(5):365-75. Review.
  217. Page A, Taylor R, Richters J, Shaw J, Taylor J, Cunningham A, Mindel A. Upstairs and downstairs: socio-economic and gender interactions in herpes simplex virus type 2 seroprevalence in Australia. Sex Transm Dis 2009;36(6):344-9.
  218. Panaretto KS, Mitchell MR, Anderson L, Gilligan C, Buettner P, Larkins SL, Eades S. Tobacco use and measuring nicotine dependence among urban Indigenous pregnant women. Med J Aust 2009;191(10):554-7.
  219. Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, Barter PJ, Rye KA, Chin-Dusting J, Hoang A, Sviridov D, Celermajer DS, Kingwell BA. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with Type 2 diabetes. J Am Coll Cardiol 2009;53(11):962-71.
  220. Paule SG, Nikolovski B, Gray RE, Ludeman JP, Freemantle A, Spark RA, Kerr JB, Ng FM, Zimmet PZ, Myers MA. GHTD-amide: a naturally occurring beta cell-derived peptide with hypoglycemic activity. Peptides 2009;30(5):955-61.
  221. Paule SG, Nikolovski B, Ludeman J, Gray RE, Spiccia L, Zimmet PZ, Myers MA. Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers. Peptides 2009;30(6):1088-97.
  222. Pedersen BK, Pedersen M, Krabbe KS, Bruunsgaard H, Matthews VB, Febbraio MA. Role of exercise-induced brain-derived neurotrophic factor production in the regulation of energy homeostasis in mammals. Exp Physiol 2009;94(12):1153-60.
  223. Peiris DP, Patel AA, Cass A, Howard MP, Tchan ML, Brady JP, De Vries J, Rickards BA, Yarnold DJ, Hayman NE, Brown AD. Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Med J Aust 2009;191(6):304-9.
  224. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators. A trial of darbepoetin alfa in Type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361(21):2019-32.
  225. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H; TREAT Investigators. Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis 2009;54(1):59-69.
  226. Pfluger HB, Murugasu A, Taylor AJ. An unexpected pericardial tumour. Intern Med J 2009;39(5):339-40.
  227. Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009;25(1):30-8. Review.
  228. Pongrac Barlovic D, Cooper ME. Arterial hypertension defeated? Attacked from another angle. Diab Vasc Dis Res 2009;6(4):221-2. Editorial.
  229. Porrello ER, Bell JR, Schertzer JD, Curl CL, McMullen JR, Mellor KM, Ritchie RH, Lynch GS, Harrap SB, Thomas WG, Delbridge LM. Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction. Am J Physiol Regul Integr Comp Physiol 2009;296(3):R672-80.
  230. Porrello ER, D'Amore A, Curl CL, Allen AM, Harrap SB, Thomas WG, Delbridge LM. Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy. Hypertension 2009;53(6):1032-40.
  231. Porrello ER, Delbridge LM, Thomas WG. The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front Biosci 2009;14:958-72. Review.
  232. Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RC, Marasco S, Medcalf RL, Ming Z, Head GA, Tan JW, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Lukoshkova EV, Dart AM, Jennings GL, McMullen JR. Reduced phosphoinositide 3-kinase (p110) activation increases the susceptibility to atrial fibrillation. Am J Pathol 2009;175(3):998-1009.
  233. Pretorius L, Owen KL, McMullen JR. Role of phosphoinositide 3-kinases in regulating cardiac function. Front Biosci 2009;14:2221-19. Review.
  234. Prior LJ, Armitage JA. Neonatal overfeeding leads to developmental programming of adult obesity: you are what you ate. J Physiol 2009;587(Pt 11):2419. Comment.
  235. Rajappan K, Baker V, Richmond L, Kistler PM, Thomas G, Redpath C, Sporton SC, Earley MJ, Harris S, Schilling RJ. A randomized trial to compare atrial fibrillation ablation using a steerable vs. a non-steerable sheath. Europace 2009;11(5):571-5.
  236. Rajic A, Stehmann C, Autelitano DJ, Vrkic AK, Hosking CG, Rice GE, Ilag LL. Protein depletion using IgY from chickens immunised with human protein cocktails. Prep Biochem Biotechnol 2009;39(3):221-47.
  237. Ramchandra R, Hood SG, Denton DA, Woods RL, McKinley MJ, McAllen RM, May CN. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proc Natl Acad Sci USA 2009;106(3):924-8.
  238. Ramm GA, Shepherd RW, Hoskins AC, Greco SA, Ney AD, Pereira TN, Bridle KR, Doecke JD, Meikle PJ, Turlin B, Lewindon PJ. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 2009;49(2):533-44.
  239. Rigor DL, Bodyak N, Bae S, Choi JH, Zhang L, Ter-Ovanesyan D, He Z, McMullen JR, Shioi T, Izumo S, King GL, Kang PM. Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase C2 in the regulation of physiologic developmental hypertrophy and heart function. Am J Physiol Heart Circ Physiol 2009;296(3):H566-72.
  240. Ritchie RH. Evidence for a causal role of oxidative stress in the myocardial complications of insulin resistance. Heart Lung Circ 2009;18:11-18. Review.
  241. Ritchie RH, Irvine JC, Rosenkranz AC, Patel R, Wendt IR, Horowitz JD, Kemp-Harper BK. Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond. Pharmacol Ther 2009;124(3):279-300.
  242. Ritchie RH, Rosenkranz AC, Kaye DM. B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target. Curr Mol Med 2009;9(7):814-25.
  243. Ritt M, Harazny JM, Ott C, Schneider MP, Schlaich MP, Michelson G, Schmieder RE. Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine. J Hypertens 2009;27(11):2201-8.
  244. Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE. Renal vascular endothelial function in hypertensive patients with Type 2 diabetes mellitus. Am J Kidney Dis 2009;53(2):281-9.
  245. Roberts BP, Krippner GY, Scanlon MJ, Chalmers DK. Molecular dynamics of variegated polyamide dendrimers. Macromolecules 2009:42(7);2784-94.
  246. Roberts BP, Scanlon MJ, Krippner GY, Chalmers DK. Molecular dynamics of poly(L-lysine) dendrimers with naphthalene disulfonate caps. Macromolecules 2009;42(7):2775-83.
  247. Roberts-Thomson KC, Kistler PM, Sanders P, Morton JB, Haqqani HM, Stevenson I, Vohra JK, Sparks PB, Kalman JM. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm 2009;6(5):587-91.
  248. Roberts-Thomson KC, Stevenson I, Kistler PM, Haqqani HM, Spence SJ, Goldblatt JC, Sanders P, Kalman JM. The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction. Heart Rhythm 2009;6(8):1109-17.
  249. Schlaich M. Central sympathetic outflow to skeletal muscle: the major link between non-esterified fatty acids and elevated blood pressure? Clin Sci 2009;118(1):43-5. Comment.
  250. Schlaich MP, Grassi G, Lambert GW, Straznicky N, Esler MD, Dixon J, Lambert EA, Redon J, Narkiewicz K, Jordan J; European Society of Hypertension Working Group on Obesity; Australian and New Zealand Obesity Society. European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens 2009;27(2):207-11. Review.
  251. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Eng J Med 2009;361(9):932-4. Letter.
  252. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009;54(6):1195-201. Review.
  253. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009;20(5):933-9.
  254. Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tübler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 2009;120(4):326-33.
  255. Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, Virmani R. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol 2009;54(23):2167-73.
  256. Shield K, Ackland ML, Ahmed N, Rice GE. Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol 2009;113(1):143-8.
  257. Shweta A, Cullen-McEwen LA, Kett MM, Evans RG, Denton KM, Fitzgerald SM, Anderson WP, Bertram JF. Glomerular surface area is normalized in mice born with a nephron deficit: no role for AT1 receptors. Am J Physiol Renal Physiol 2009;296(3):F583-9.
  258. Singh RR, Denton KM, Bertram JF, Jefferies AJ, Head GA, Lombardo P, Schneider-Kolsky M, Moritz KM. Development of cardiovascular disease due to renal insufficiency in male sheep following fetal unilateral nephrectomy. J Hypertens 2009;27(2):386-96.
  259. Skilton MR, Sérusclat A, Begg LM, Moulin P, Bonnet F. Parity and carotid atherosclerosis in men and women: insights into the roles of childbearing and child-rearing. Stroke 2009;40(4):1152-7.
  260. Skilton MR, Sérusclat A, Sethu AH, Brun S, Bernard S, Balkau B, Moulin P, Bonnet F. Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness. JACC Cardiovasc Imaging 2009;2(2):176-82.
  261. Sochalski J, Jaarsma T, Krumholz HM, Laramee A, McMurray JJ, Naylor MD, Rich MW, Riegel B, Stewart S. What works in chronic care management: the case of heart failure. Health Aff 2009;28(1):179-89.
  262. Söderberg S, Colquhoun D, Keech A, Yallop J, Barnes EH, Pollicino C, Simes J, Tonkin AM, Nestel P, LIPID Study Investigators. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Int J Obes 2009;33(1):123-30.
  263. Soldatos G, Cooper ME. Does intensive glycemic control for Type 2 diabetes mellitus have long-term benefits for cardiovascular disease risk? Nat Clin Pract Endocrinol Metab 2009;5(3):138-9.
  264. Sorbello D, Dewey HM, Churilov L, Thrift AG, Collier JM, Donnan G, Bernhardt J. Very early mobilisation and complications in the first 3 months after stroke: further results from Phase II of A Very Early Rehabilitation Trial (AVERT). Cerebrovasc Dis 2009;28(4):378-83.
  265. Sourris KC, Forbes JM. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets. Curr Drug Targets 2009;10(1):42-50. Review.
  266. Sourris KC, Harcourt BE, Forbes JM. A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches? Am J Nephrol 2009;30(4):323-35. Review.
  267. Sourris KC, Lyons JG, de Courten MP, Dougherty SL, Henstridge DC, Cooper ME, Hage M, Dart A, Kingwell BA, Forbes JM, de Courten B. c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-B activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 2009;58(6):1259-65.
  268. Steinberg GR, Watt MJ, Febbraio MA. Cytokine regulation of AMPK signalling. Front Biosci 2009;14:1902-16. Review.
  269. Stewart S. Population screening for heart disease in vulnerable populations: lessons from the Heart of Soweto Study. Heart Lung Circ 2009;18(2):104-6. Review.
  270. Stewart S, Sliwa K. Preventing CVD in resource-poor areas: perspectives from the 'real-world'. Nat Rev Cardiol 2009;6(7):489-92. Review.
  271. Stieglar RS, Zimmet PZ, Cameron AJ, Shaw JE. Lifestyle management: preventing Type 2 diabetes and cardiovascular complications. Therapy 2009;6(4):489-96. Review.
  272. Straznicky NE, Lambert EA. (Reply to Jindal RD) Autonomic response to oral glucose in those with metabolic syndrome. Am J Clin Nutr 2009;89(6):1948-9. Author reply.
  273. Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr 2009;89(1):27-36.
  274. Straznicky NE, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ, Eikelis N, Schlaich MP, Esler MD, Socratous F, Chopra R, Lambert EA. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese metabolic syndrome subjects. Diabetes 2009;58(5):1126-32.
  275. Sviridov D. Maturation of apolipoprotein A-I: unrecognized health benefit or a forgotten rudiment? J Lipid Res 2009;50(7):1257-8. Comment.
  276. Tanamas S, Hanna FS, Cicuttini FM, Wluka AE, Berry P, Urquhart DM. Does knee malalignment increase the risk of development and progression of knee osteoarthritis? A systematic review. Arthritis Rheum 2009;61(4):459-67. Review.
  277. Teh AW, Kistler PM, Kalman JM. Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia. J Cardiovasc Electrophysiol 2009;20(6):706-9; quiz 705. Review.
  278. Teichtahl AJ, Wluka AE, Forbes A, Wang Y, English DR, Giles GG, Cicuttini FM. Longitudinal effect of vigorous physical activity on patella cartilage morphology in people without clinical knee disease. Arthritis Rheum 2009;61(8):1095-102.
  279. Teichtahl AJ, Wluka AE, Morris ME, Davis SR, Cicuttini FM. The associations between the dominant and nondominant peak external knee adductor moments during gait in healthy subjects: evidence for symmetry. Arch Phys Med Rehabil 2009;90(2):320-4.
  280. Teichtahl AJ, Wluka AE, Wang Y, Hanna F, English DR, Giles GG, Cicuttini FM. Obesity and adiposity are associated with the rate of patella cartilage volume loss over two years in adults without knee osteoarthritis. Ann Rheum Dis 2009;68(6):909-13.
  281. Telford RD, Bass SL, Budge MM, Byrne DG, Carlson JS, Coles D, Cunningham RB, Daly RM, Dunstan DW, English R, Fitzgerald R, Eser P, Gravenmaker KJ, Haynes W, Hickman PE, Javaid A, Jiang X, Lafferty T, McGrath M, Martin MK, Naughton GA, Potter JM, Potter SJ, Prosser L, Pyne DB, Reynolds GJ, Saunders PU, Seibel MJ, Shaw JE, Southcott E, Srikusalanukul W, Stuckey D, Telford RM, Thomas K, Tallis K, Waring P. The Lifestyle Of Our Kids (LOOK) project: outline of methods. J Sci Med Sport 2009;12(1):156-163.
  282. Telford RD, Cunningham RB, Shaw JE, Dunstan DW, Lafferty AR, Reynolds GJ, Hickman PE, Southcott E, Potter JM, Waring P, Telford RM. Contrasting longitudinal and cross-sectional relationships between insulin resistance and percentage of body fat, fitness, and physical activity in children-the LOOK study. Pediatr Diabetes 2009;10(8):500-7.
  283. Thomas MC, Atkins R. Assessment and management of hypertension in patients with Type 2 diabetes. Intern Med J 2009;39(3):143-9.
  284. Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, Atkins RC. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (National Evaluation of the Frequency of Renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 2009;32(8):1497-502.
  285. Thomas MC, Tikellis C. Losing control: positive and negative feedback in the renin angiotensin system. Curr Hypertens Rev 2009;5(3):222-6. Review.
  286. Thrift AG. Types of randomised controlled trials. Neuroepidemiology 2009:33(4);319-20. Review.
  287. Thrift AG, Dewey HM, Sturm JW, Srikanth VK, Gilligan AK, Gall SL, Macdonell RA, McNeil JJ, Donnan GA. Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women. Neuroepidemiology 2009;32(1):11-8.
  288. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, Stewart S. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study "Heart Awareness Days". Int J Cardiol 2009;132(2):233-9.
  289. Tikellis C, Koh P, Burns W, Kantharidis P. Quantitative gene expression analysis in kidney tissues. Methods Mol Biol 2009;466:83-107.
  290. Tikellis G, Gillies MC, Guymer RH, McAllister IL, Shaw JE, Wong TY. Retinal vascular caliber and macular telangiectasia type 2. Ophthalmology 2009;116(2):319-23.
  291. To K, Agrotis A, Besra G, Bobik A, Toh BH. NKT cell subsets mediate differential proatherogenic effects in ApoE-/- mice. Arterioscler Thromb Vasc Biol 2009;29(5):671-7.
  292. Tonna S. Invited commentary: defining incident chronic kidney disease in epidemiologic study settings. Am J Epidemiol 2009;170(4):425-7. Comment.
  293. Turner C, Bain C, Schluter PJ, Yorkston E, Bogossian F, McClure R, Huntington A; Nurses and Midwives e-cohort Group. Cohort Profile: The Nurses and Midwives e-Cohort Study--a novel electronic longitudinal study. Int J Epidemiol 2009:38(1);53-60.
  294. Turpin SM, Ryall JG, Southgate R, Darby I, Hevener AL, Febbraio MA, Kemp BE, Lynch GS, Watt MJ. Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. J Physiol 2009;587(Pt 7):1593-605.
  295. Venardos K, Enriquez C, Marshall T, Chin-Dusting JP, Ahlers B, Kaye DM. Protein kinase C mediated inhibition of endothelial L-arginine transport is mediated by MARCKS protein. J Mol Cell Cardiol 2009;46(1):86-92.
  296. Venardos K, Zhang WZ, Lang C, Kaye DM. Effect of peroxynitrite on endothelial L-arginine transport and metabolism. Int J Biochem Cell Biol 2009;41(12):2522-7.
  297. Venardos KM, Zatta AJ, Marshall T, Ritchie R, Kaye DM. Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury. J Cell Biochem 2009;108(1):156-68.
  298. Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S; ONTARGET/TRANSCEND Investigators. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in ONTARGET and TRANSCEND. Circulation 2009;120(14):1380-9.
  299. Vistisen D, Colagiuri S, Borch-Johnsen K; DETECT-2 Collaboration. Bimodal distribution of glucose is not universally useful for diagnosing diabetes. Diabetes Care 2009;32(3):397-403.
  300. von Zur Muhlen C, Peter K, Ali ZA, Schneider JE, McAteer MA, Neubauer S, Channon KM, Bode C, Choudhury RP. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J Vasc Res 2009;46(1):6-14.
  301. von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res 2009;8(1):335-345.
  302. Voruganti VS, Nath SD, Cole SA, Thameem F, Jowett JB, Bauer R, Maccluer JW, Blangero J, Comuzzie AG, Abboud HE, Arar NH. Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican-Americans. J Clin Endocrinol Metab 2009;94(2):632-638.
  303. Walker KZ, Woods J, Ross J, Hechtman R. Yoghurt and dairy snacks presented for sale to an Australian consumer: are they becoming less healthy? Public Health Nutr 2009;22:1-6.
  304. Wand AP, Corr MJ, Eades SJ. Liaison psychiatry with Aboriginal and Torres Strait Islander peoples. Aust N Z J Psychiatry 2009;43(6):509-17.
  305. Wang X, McLennan SV, Allen TJ, Tsoutsman T, Semsarian C, Twigg SM. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor. Am J Physiol Cell Physiol 2009;297(6):C1490-500.
  306. Wang Y, Davies-Tuck ML, Wluka AE, Forbes A, English DR, Giles GG, O'Sullivan R, Cicuttini FM. Dietary fatty acid intake affects the risk of developing bone marrow lesions in healthy middle-aged adults without clinical knee osteoarthritis: a prospective cohort study. Arthritis Res Ther 2009;11(3):R63.
  307. Wang Y, Simpson JA, Wluka AE, Teichtahl AJ, English DR, Giles GG, Graves S, Cicuttini FM. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: a prospective cohort study. Arthritis Res Ther 2009;11(2):R31.
  308. Wang Y, Simpson JA, Wluka AE, Urquhart DM, English DR, Giles GG, Graves S, Cicuttini FM. Reduced rates of primary joint replacement for osteoarthritis in Italian and Greek migrants to Australia: the Melbourne Collaborative Cohort Study. Arthritis Res Ther 2009;11(3):R86.
  309. Watt MJ, Bruce CR. No need to sweat: is dieting enough to alleviate insulin resistance in obesity? J Physiol 2009;587(Pt 21):5001-2. Review.
  310. White AJ, Duffy SJ, Walton AS, Mukherjee S, Shaw JA, Jennings GL, Dart AM, Kingwell BA. Compliance mismatch between stenotic and distal reference segment is associated with coronary artery disease instability. Atherosclerosis 2009;206(1):179-85.
  311. White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant 2009;24(8):2464-72.
  312. Wijndaele K, Lynch BM, Owen N, Dunstan DW, Sharp S, Aitken JF. Television viewing time and weight gain in colorectal cancer survivors: a prospective population-based study. Cancer Causes Control 2009;20(8):1355-62.
  313. Wluka AE, Hanna FS, Davies-Tuck M, Wang Y, Bell RJ, Davis SR, Adams J, Cicuttini FM. Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years. Ann Rheum Dis 2009;68(6):850-5.
  314. Wong A, Woodcock EA. FoxO proteins and cardiac pathology. Adv Exp Med Biol 2009;665:78-89.
  315. Wong N, Wang SS, Lamoureux E, Wong TY, Tikellis G, Harper A, Wang JJ. Blood pressure control and awareness among patients with diabetes and hypertension attending a tertiary ophthalmic clinic. Diabet Med 2009;26(1):34-9.
  316. Woodcock EA, Grubb DR, Filtz TM, Marasco S, Luo J, McLeod-Dryden TJ, Kaye DM, Sadoshima J, Du XJ, Wong C, McMullen JR, Dart AM. Selective activation of the "b" splice variant of phospholipase C1 in chronically dilated human and mouse atria. J Mol Cell Cardiol 2009;47(5):676-83.
  317. Woodcock EA, Kistler PM, Ju YK. Phosphoinositide signalling and cardiac arrhythmias. Cardiovasc Res 2009;82(2):286-95. Review.
  318. Woollard KJ, Sturgeon S, Chin-Dusting JP, Salem HH, Jackson SP. Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem 2009;284(19):13110-8.
  319. Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy SJ, Shardey GC, Skillington PD, Farouque O, Yii M, Yap CH, Andrianopoulos N, Brennan A, Dinh D, Reid CM; Australasian Society of Cardiac and Thoracic Surgeons (ASCTS); Melbourne Interventional Group (MIG). Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries. Heart Lung Circ 2009;18(3):184-90.
  320. Yang SN, Burch ML, Getachew R, Ballinger ML, Osman N, Little PJ. Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation. Arch Physiol Biochem 2009;115(3):147-54.
  321. Yang SNY, Osman N, Burch ML, Little PJ. Factors affecting proteoglycan synthesis and structure that modify the interaction with lipoproteins. Clin Lipidol 2009;4(4):479-92.
  322. Yang Z, Kaye DM. Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension. Hum Mutat 2009;30(3):328-33.
  323. Yuen DY, Dwyer RM, Matthews VB, Zhang L, Drew BG, Neill B, Kingwell BA, Clark MG, Rattigan S, Febbraio MA. Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression. Diabetes 2009;58(5):1086-95.
  324. Zimmet P. Preventing diabetic complications: a primary care perspective. Diabetes Res Clin Pract 2009;84(2):107-16. Review.
  325. Zimmet PZ. A lifetime pursuit of diabetes through chance. Med J Aust 2009;191(11-12):632-6. Personal profile.

Book chapters

  1. Cameron AJ, Shaw J, Zimmet P. Diabetes and the metabolic syndrome. In: Tonkin AM (ed), Therapeutic Strategies in Lipid Disorders, Clinical Publishing Elsevier, Oxford. 2009; pp87-105.
  2. Masuo K, Lambert GW, Esler MD. The roles of insulin resistance and sympathetic nerve activity in obesity and hypertension - which comes first in hypertension and obesity? In: Insulin Resistance: New Research, Yao EB (ed), Nova Science Publishers, New York. 2009; pp277-300.
  3. Masuo K, Lambert GW, Esler MD. The roles of insulin resistance and sympathetic nerve activity in obesity and hypertension - which comes first the blood pressure or weight? In: Neurochemistry: Molecular Aspects, Cellular Aspects and Clinical Applications, Paços A, Nogueira S (eds), Nova Science Publishers, New York. 2009; pp151-66.
  4. Reutens AT, Atkins RC. Chronic kidney disease (CKD): the scope of the global problem. In: El Nahas M, Levin A (eds), Chronic Kidney Disease: A Practical Guide to Understanding and Management. Oxford University Press, Oxford. 2009; pp39-75.
  5. Shaw JE, Simpson RW. Prevention of Type 2 diabetes. In: Regensteiner JG, Reusch JEB, Stewart KJ, Veves A (eds), Diabetes and Exercise, Humana Press, New York. 2009; pp55-81.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more